The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution
Open accessAbstract
Germline mutations of the breast cancer associated gene 1 (BRCA1) predispose women to breast and ovarian cancers. BRCA1 is a large protein with multiple functional domains and interacts with numerous proteins that are involved in many important biological processes/pathways. Mounting evidence indicates that BRCA1 is involved in all phases of the cell cycle and regulates orderly events during cell cycle progression. BRCA1 deficiency, consequently causes abnormalities in the S-phase checkpoint, the G(2)/M checkpoint, the spindle checkpoint and centrosome duplication. The genetic instability caused by BRCA1 deficiency, however, also triggers cellular responses to DNA damage that blocks cell proliferation and induces apoptosis. Thus BRCA1 mutant cells cannot develop further into full-grown tumors unless this cellular defense is broken. Functional analysis of BRCA1 in cell cycle checkpoints, genome integrity, DNA damage response (DDR) and tumor evolution should benefit our understanding of the mechanisms underlying BRCA1 associated tumorigenesis, as well as the development of therapeutic approaches for this lethal disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
BRCA1 Phosphorylation by Aurora-A in the Regulation of G2 to M Transition
Ouchi, M., Fujiuchi, N., Sasai, K., Katayama, H., Minamishima, Y. A., Ongusaha, P. P., Deng, C., Sen, S., Lee, S. W., & Ouchi, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311780200 · Cited by 199
Self-citationRetractedWAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
Hall, J. M., Lee, M. K., Newman, B., Morrow, J. E., Anderson, L. A., Huey, B., & King, M.-C. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,550
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,281
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Self-citationCell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,039
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
Venkitaraman, A. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00615-3 · Cited by 1,713
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Easton, D. F., Ford, D., & Bishop, D. T. (1995) · PubMed Central · Cited by 1,602
Lowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation
Zhou, H., Kuang, J., Zhong, L., Kuo, W.-L., Gray, J., Sahin, A., Brinkley, B., & Sen, S. (1998) · Nature Genetics · doi:10.1038/2496 · Cited by 1,276
Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386761a0 · Cited by 1,240
A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
Bischoff, J. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3052 · Cited by 1,216
On the road to cancer: aneuploidy and the mitotic checkpoint
Kops, G. J. P. L., Weaver, B. A. A., & Cleveland, D. W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1714 · Cited by 1,185
Cortez, D., Wang, Y., Qin, J., & Elledge, S. J. (1999) · Science · doi:10.1126/science.286.5442.1162 · Cited by 1,020
Cleveland, D. W., Mao, Y., & Sullivan, K. F. (2003) · Cell · doi:10.1016/s0092-8674(03)00115-6 · Cited by 1,003
The Anaphase-Promoting Complex
Peters, J.-M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00540-3 · Cited by 909
Sudakin, V., Chan, G. K. T., & Yen, T. J. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200102093 · Cited by 902
MDC1 is a mediator of the mammalian DNA damage checkpoint
Stewart, G. S., Wang, B., Bignell, C. R., Taylor, A. M. R., & Elledge, S. J. (2003) · Nature · doi:10.1038/nature01446 · Cited by 874
Xu, X., Weaver, Z., Linke, S. P., Li, C., Gotay, J., Wang, X.-W., Harris, C. C., Ried, T., & Deng, C.-X. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80466-9 · Cited by 819
Self-citationXu, X., Wagner, K.-U., Larson, D., Weaver, Z., Li, C., Ried, T., Hennighausen, L., Wynshaw-Boris, A., & Deng, C.-X. (1999) · Nature Genetics · doi:10.1038/8743 · Cited by 758
Self-citationIdentification of a RING protein that can interact in vivo with the BRCA1 gene product
Wu, L. C., Wang, Z. W., Tsan, J. T., Spillman, M. A., Phung, A., Xu, X. L., Yang, M.-C. W., Hwang, L.-Y., Bowcock, A. M., & Baer, R. (1996) · Nature Genetics · doi:10.1038/ng1296-430 · Cited by 746
Miki, T., Bottaro, D. P., Fleming, T. P., Smith, C. L., Burgess, W. H., Chan, A. M., & Aaronson, S. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.246 · Cited by 746
MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells
Michel, L. S., Liberal, V., Chatterjee, A., Kirchwegger, R., Pasche, B., Gerald, W., Dobles, M., Sorger, P. K., Murty, V. V. V. S., & Benezra, R. (2001) · Nature · doi:10.1038/35053094 · Cited by 723
How Cells Get the Right Chromosomes
Nicklas, R. B. (1997) · Science · doi:10.1126/science.275.5300.632 · Cited by 609
Thompson, M. E., Jensen, R. A., Obermiller, P. S., Page, D. L., & Holt, J. T. (1995) · Nature Genetics · doi:10.1038/ng0495-444 · Cited by 585
Induction of GADD45 and JNK/SAPK-Dependent Apoptosis following Inducible Expression of BRCA1
Harkin, D. P., Bean, J. M., Miklos, D., Song, Y.-H., Truong, V. B., Englert, C., Christians, F. C., Ellisen, L. W., Maheswaran, S., Oliner, J. D., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80769-2 · Cited by 557
Involvement of Brca1 in S-Phase and G 2 -Phase Checkpoints after Ionizing Irradiation
Xu, B., Kim, S.-T., & Kastan, M. B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3445-3450.2001 · Cited by 540
Ludwig, T., Chapman, D. L., Papaioannou, V. E., & Efstratiadis, A. (1997) · Genes & Development · doi:10.1101/gad.11.10.1226 · Cited by 539
hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response
Lee, J.-S., Collins, K. M., Brown, A. L., Lee, C.-H., & Chung, J. H. (2000) · Nature · doi:10.1038/35004614 · Cited by 529
Chromosome Missegregation and Apoptosis in Mice Lacking the Mitotic Checkpoint Protein Mad2
Dobles, M., Liberal, V., Scott, M. L., Benezra, R., & Sorger, P. K. (2000) · Cell · doi:10.1016/s0092-8674(00)80875-2 · Cited by 524
Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress
Tibbetts, R. S., Cortez, D., Brumbaugh, K. M., Scully, R., Livingston, D., Elledge, S. J., & Abraham, R. T. (2000) · Genes & Development · doi:10.1101/gad.851000 · Cited by 512
Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl
Somasundaram, K., Zhang, H., Zeng, Y.-X., Houvras, Y., Peng, Y., Zhang, H., Wu, G. S., Licht, J. D., Weber, B. L., & El-Deiry, W. S. (1997) · Nature · doi:10.1038/38291 · Cited by 509
BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage
Yarden, R. I., Pardo-Reoyo, S., Sgagias, M., Cowan, K. H., & Brody, L. C. (2002) · Nature Genetics · doi:10.1038/ng837 · Cited by 484
Identification of microcephalin, a protein implicated in determining the size of the human brain
Jackson, A. P., Eastwood, H., Bell, S. M., Adu, J., Toomes, C., Carr, I. M., Roberts, E., Hampshire, D. J., Crow, Y. J., Mighell, A. J., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/341283 · Cited by 482
ATAXIA-TELANGIECTASIA AND THE NIJMEGEN BREAKAGE SYNDROME: Related Disorders But Genes Apart
Shiloh, Y. (1997) · Annual Review of Genetics · doi:10.1146/annurev.genet.31.1.635 · Cited by 481
14-3-3 proteins: regulation of subcellular localization by molecular interference
MUSLIN, A. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(00)00131-5 · Cited by 417
BRCA1, Histone H2AX Phosphorylation, and Male Meiotic Sex Chromosome Inactivation
Turner, J. M. A., Aprelikova, O., Xu, X., Wang, R., Kim, S., Chandramouli, G. V. R., Barrett, J. C., Burgoyne, P. S., & Deng, C.-X. (2004) · Current Biology · doi:10.1016/j.cub.2004.11.032 · Cited by 410
Self-citationMad2-Independent Inhibition of APCCdc20 by the Mitotic Checkpoint Protein BubR1
Tang, Z., Bharadwaj, R., Li, B., & Yu, H. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00019-3 · Cited by 410
The Aurora kinases: Role in cell transformation and tumorigenesis
Katayama, H., Brinkley, W. R., & Sen, S. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023789416385 · Cited by 398
Amon, A. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80010-0 · Cited by 395
Xu, X., Qiao, W., Linke, S. P., Cao, L., Li, W.-M., Furth, P. A., Harris, C. C., & Deng, C.-X. (2001) · Nature Genetics · doi:10.1038/90108 · Cited by 373
Self-citationMultiple Tumor Suppressor Pathways Negatively Regulate Telomerase
Lin, S.-Y., & Elledge, S. J. (2003) · Cell · doi:10.1016/s0092-8674(03)00430-6 · Cited by 363
Growth retardation and tumour inhibition by BRCA1
Holt, J. T., Thompson, M. E., Szabo, C., Robinson-Benion, C., Arteaga, C. L., King, M.-C., & Jensen, R. A. (1996) · Nature Genetics · doi:10.1038/ng0396-298 · Cited by 361
Genetic Analysis of BRCA1 Function in a Defined Tumor Cell Line
Scully, R., Ganesan, S., Vlasakova, K., Chen, J., Socolovsky, M., & Livingston, D. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80238-5 · Cited by 359
Tirkkonen, M., Johannsson, O. T., Agnarsson, B. A., Olsson, H. L., Ingvarsson, S., Karhu, R., Tanner, M., Isola, J. J., Barkardottir, R. B., Borg, Å., et al. (1997) · PubMed · Cited by 354
Regulation of APC–Cdc20 by the spindle checkpoint
Yu, H. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00382-4 · Cited by 338
Aurora kinases link chromosome segregation and cell division to cancer susceptibility
Meraldi, P., Honda, R., & Nigg, E. A. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.11.006 · Cited by 336
Donehower, L. A., & Bradley, A. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90004-v · Cited by 333
Checkpoint Protein BubR1 Acts Synergistically with Mad2 to Inhibit Anaphase-promoting Complex
Fang, G. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-09-0437 · Cited by 330
BRCA1 interacts with components of the histone deacetylase complex
Yarden, R. I., & Brody, L. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4983 · Cited by 330
Shen, S.-X., Weaver, Z., Xu, X., Li, C., Weinstein, M., Chen, L., Guan, X.-Y., Ried, T., & Deng, C.-X. (1998) · Oncogene · doi:10.1038/sj.onc.1202243 · Cited by 329
Self-citationRoles of BRCA1 and its interacting proteins
Deng, C.-X., & Brodie, S. G. (2000) · BioEssays · doi:10.1002/1521-1878(200008)22:8<728::aid-bies6>3.0.co;2-b · Cited by 320
Self-citationCentrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast.
Tanaka, T., Kimura, M., Matsunaga, K., Fukada, D., Mori, H., & Okano, Y. (1999) · PubMed · Cited by 301
Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier.
Tomlinson, G. E., Chen, T. T., Stastny, V., Virmani, A. K., Spillman, M. A., Tonk, V. S., Blum, J. L., Schneider, N. R., Wistuba, I. I., Shay, J. W., et al. (1998) · PubMed · Cited by 294
Cao, L., Li, W., Kim, S., Brodie, S. G., & Deng, C.-X. (2003) · Genes & Development · doi:10.1101/gad.1050003 · Cited by 293
Self-citationSilver, D. P., & Livingston, D. M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00295-7 · Cited by 293
Aurora kinases, aneuploidy and cancer, a coincidence or a real link?
Giet, R., Petretti, C., & Prigent, C. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.03.004 · Cited by 262
The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity
Baer, R. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00269-6 · Cited by 260
Partial rescue of Brca15–6 early embryonic lethality by p53 or p21 null mutation
Hakem, R., de la Pompa, J. L., Elia, A., Potter, J., & Mak, T. W. (1997) · Nature Genetics · doi:10.1038/ng0797-298 · Cited by 252
Localization of BRCA1 and a Splice Variant Identifies the Nuclear Localization Signal
Thakur, S., Zhang, H. B., Peng, Y., Le, H., Carroll, B., Ward, T., Yao, J., Farid, L. M., Couch, F. J., Wilson, R. B., et al. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.444 · Cited by 231
Gorbsky, G. J., Chen, R.-H., & Murray, A. W. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.5.1193 · Cited by 218
The Role of the BRCA1 Tumor Suppressor in DNA Double-Strand Break Repair
Zhang, J., & Powell, S. N. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0192 · Cited by 209
Lane, T. F., Deng, C., Elson, A., Lyu, M. S., Kozak, C. A., & Leder, P. (1995) · Genes & Development · doi:10.1101/gad.9.21.2712 · Cited by 197
Self-citationBRCA1 is a cell cycle-regulated nuclear phosphoprotein
Ruffner, H., & Verma, I. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7138 · Cited by 196
Wilson, C. A., Payton, M. N., Elliott, G. S., Buaas, F. W., Cajulis, E. E., Grosshans, D., Ramos, L., Reese, D. M., Slamon, D. J., & Calzone, F. J. (1997) · Oncogene · doi:10.1038/sj.onc.1200924 · Cited by 193
Gatei, M., Zhou, B.-B., Hobson, K., Scott, S., Young, D., & Khanna, K. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011681200 · Cited by 191
Xu, B., O’Donnell‐Luria, A., Kim, S., & Kastan, M. B. (2002) · PubMed · Cited by 190
Brodie, S. G., Xu, X., Qiao, W., Li, W.-M., Cao, L., & Deng, C.-X. (2001) · Oncogene · doi:10.1038/sj.onc.1204929 · Cited by 188
Self-citationAurora kinases in spindle assembly and chromosome segregation
DUCAT, D., & ZHENG, Y. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.08.016 · Cited by 173
Lin, S.-Y., Rai, R., Li, K., Xu, Z.-X., & Elledge, S. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507722102 · Cited by 172
Roles of BRCA1 in DNA damage repair: a link between development and cancer
Deng, C.-X. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg082 · Cited by 168
Self-citationFabbro, M., Savage, K., Hobson, K., Deans, A. J., Powell, S. N., McArthur, G. A., & Khanna, K. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405372200 · Cited by 163
A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint
Wang, R.-H., Yu, H., & Deng, C.-X. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407585101 · Cited by 163
Self-citationBreast Cancer Susceptibility Genes: BRCA1 and BRCA2
Brody, L. C., & Biesecker, B. B. (1998) · Medicine · doi:10.1097/00005792-199805000-00006 · Cited by 163
BRCA1-associated growth arrest is RB-dependent
Aprelikova, O. N., Fang, B. S., Meissner, E. G., Cotter, S., Campbell, M., Kuthiala, A., Bessho, M., Jensen, R. A., & Liu, E. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11866 · Cited by 158
Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation
Deng, C.-X., & Scott, F. (2000) · Oncogene · doi:10.1038/sj.onc.1203269 · Cited by 158
Self-citationOhler, Z. W., Montagna, C., Xu, X., Howard, T. A., Gadina, M., Brodie, S. G., Deng, C., & Ried, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205636 · Cited by 156
Self-citationCrane, R. F., Gadea, B. B., Littlepage, L. E., Wu, H., & RUDERMAN, J. V. (2004) · Biology of the Cell · doi:10.1016/j.biolcel.2003.09.008 · Cited by 154
Zhang, D., Hirota, T., Marumoto, T., Shimizu, M., Kunitoku, N., Sasayama, T., Arima, Y., Feng, L., Suzuki, M., Takeya, M., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208153 · Cited by 147
BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.
Vaughn, J. P., Davis, P. L., Jarboe, M. D., Hüper, G., Evans, A. C., Wiseman, R. W., Berchuck, A., Iglehart, J. D., Futreal, P. A., & Marks, J. R. (1996) · PubMed · Cited by 145
Tanaka, E. I., Hashimoto, Y., Ito, T., Okumura, T., Kan, T., Watanabe, G., Imamura, M., Inazawa, J., & Shimada, Y. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1627 · Cited by 130
Roles of BRCA1 in centrosome duplication
Deng, C. (2002) · Oncogene · doi:10.1038/sj.onc.1205713 · Cited by 120
Self-citationEpidemiology, prevention, and early detection of breast cancer
Daudt, A. W., Alberg, A. J., & Helzlsouer, K. J. (1996) · Current Opinion in Oncology · doi:10.1097/00001622-199611000-00003 · Cited by 116
Ghimenti, C., Sensi, E., Presciuttini, S., Brunetti, I. M., Conte, P., Bevilacqua, G., & Caligo, M. A. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1223 · Cited by 110
Mad2 phosphorylation regulates its association with Mad1 and the APC/C
Wassmann, K., Liberal, V., & Benezra, R. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg071 · Cited by 105
Identification of BRCA1-IRIS, a BRCA1 locus product
ElShamy, W. M., & Livingston, D. M. (2004) · Nature Cell Biology · doi:10.1038/ncb1171 · Cited by 101
Many Fingers on the Mitotic Trigger: Post-Translational Regulation of the Cdc25C Phosphatase
Hutchins, J. R. A., & Clarke, P. R. (2004) · Cell Cycle · doi:10.4161/cc.3.1.595 · Cited by 89
Regulation of BRCA1, BRCA2 and BARD1 intracellular trafficking
Henderson, B. R. (2005) · BioEssays · doi:10.1002/bies.20277 · Cited by 82
BRCA1-associated tumorigenesis: what have we learned from knockout mice?
Brodie, S. G., & Deng, C. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02451-9 · Cited by 81
Self-citationGood Timing in the Cell Cycle for Precise DNA Repair by BRCA1
Durant, S. T., & Nickoloff, J. A. (2005) · Cell Cycle · doi:10.4161/cc.4.9.2027 · Cited by 78
Okada, S., & Ouchi, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208685200 · Cited by 76
Mutational analysis of BARD1 in familial breast cancer patients in Japan
Ishitobi, M., Miyoshi, Y., Hasegawa, S., Egawa, C., Tamaki, Y., Monden, M., & Noguchi, S. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00387-2 · Cited by 74
Is TP53 dysfunction required for BRCA1-associated carcinogenesis?
Schuyer, M., & Berns, E. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00117-3 · Cited by 73
BRCA1 Regulates Gene Expression for Orderly Mitotic Progression
Bae, I., Rih, J. K., Kim, H. J., et al. (2005) · Cell Cycle · doi:10.4161/cc.4.11.2152 · Cited by 68
Collaboration of Brca1 and Chk2 in tumorigenesisPreprint
McPherson, J. P., Lemmers, B., Hirao, A., Hakem, A., Abraham, J., Migon, E., Matysiak‐Zablocki, E., Tamblyn, L., Sanchez-Sweatman, O. H., Khokha, R., et al. (2004) · Genes & Development · doi:10.1101/gad.1192704 · Cited by 68
The effects of tamoxifen on the female genital tract
Senkus, E., Konefka, T., & Jassem, J. (2003) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.09.004 · Cited by 64
Tumor formation in Brca1 conditional mutant mice
Deng, C. (2002) · Environmental and Molecular Mutagenesis · doi:10.1002/em.10069 · Cited by 61
Self-citationTumorigenesis as a consequence of genetic instability in Brca1 mutant mice
Deng, C. (2001) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(01)00119-1 · Cited by 53
Self-citationKim, S. S., Cao, L., Li, C., Xu, X., Huber, L. J., Chodosh, L. A., & Deng, C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9498-9507.2004 · Cited by 52
Self-citationEpidemiology, prevention, and early detection of breast cancer
Alberg, A. J., Lam, A. P., & Helzlsouer, K. J. (1999) · Current Opinion in Oncology · doi:10.1097/00001622-199911000-00003 · Cited by 50
Brcal: A Review of Structure and Putative Functions
Paterson, J. W. E. (1998) · Disease Markers · doi:10.1155/1998/298530 · Cited by 42
Assessing the Link between BACH1 and BRCA1 in the FA Pathway
Cantor, S. B., & Andreassen, P. R. (2005) · Cell Cycle · doi:10.4161/cc.5.2.2338 · Cited by 39
Familial non-BRCA1/BRCA2-associated breast cancer
Eccles, D., & Pichert, G. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70318-1 · Cited by 38
Simeone, A., Deng, C., Kelloff, G. J., Steele, V. E., Johnson, M. M., & Tari, A. M. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi038 · Cited by 27
Self-citationShorrocks, J., Tobi, S., Latham, H., Peacock, J. H., Eeles, R. A., Eccles, D., & McMillan, T. J. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.09.042 · Cited by 19
張, 東. (2005) · Medical Entomology and Zoology · Cited by 13
Cited by
Risk Factors and Preventions of Breast Cancer
Sun, Y.-S., Zhao, Z., Yang, Z.-N., Xu, F., Lu, H.-J., Zhu, Z.-Y., Shi, W., Jiang, J., Yao, P.-P., & Zhu, H.-P. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.21635 · Cited by 2,003
53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
Bunting, S. F., Callén, E., Wong, N., Chen, H.-T., Polato, F., Gunn, A., Bothmer, A., Feldhahn, N., Fernandez-Capetillo, O., Cao, L., et al. (2010) · Cell · doi:10.1016/j.cell.2010.03.012 · Cited by 1,671
Self-citationCancer as an evolutionary and ecological process
Merlo, L. M. F., Pepper, J. W., Reid, B. J., & Maley, C. C. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2013 · Cited by 1,699
Intrinsically Disordered Proteins in Human Diseases: Introducing the D2Concept
Uversky, V. N., Oldfield, C. J., & Dunker, A. K. (2008) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.37.032807.125924 · Cited by 1,410
Bouwman, P., Aly, A., Escandell, J. M., Pieterse, M., Bartkova, J., van der Gulden, H., Hiddingh, S., Thanasoula, M., Kulkarni, A., Yang, Q., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1831 · Cited by 1,001
Metadata
- Authors
- Deng, C.-X.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-03-06
- Volume
- 34
- Issue
- 5
- Pages
- 1416-1426
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W1989059483
- Cited by
- 584
- References
- 116
- FWCI
- 19.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.